BERKELEY, CA (UroToday.com) - The AUA Guidelines on Early Detection of Prostate Cancer suggest a PSA-based prostate cancer screening in men younger than 55 years of age with a positive family history.
In recent years, several new biomarkers supplementing the role of prostate-specific antigen (PSA) have become available for men with prostate cancer. Although widely used in an ad hoc manner, the role of PSA in screening asymptomatic men for prostate cancer is controversial.
BERKELEY, CA (UroToday.com) - Although there is controversy over the benefit of PSA screening, early detection of prostate cancer in young men could reduce cancer-specific mortality. [-2]proPSA (p2PSA) and Prostate Health Index (PHI) represent new promising biomarkers.
To assess the economic impact of introducing the prostate health index (phi) for prostate cancer (PCa) detection.
A total of 177 patients who presented in an academic institution with a tPSA between 2 and 10 ng/ml and underwent prostate biopsies within the 3 months were enrolled.
BERKELEY, CA (UroToday.com) - In this recent study by Ju, et al., mRNA-based diagnostic and prognostic tests were developed and used to interrogate two retrospective clinical studies.
Login to update email address, newsletter preferences and use bookmarks.